((自动化翻译由路透提供，请见免责声明 ))
11月1日 - ** 生物技术公司 ChromaDex 的 股价盘前上涨 ~17.7% 至 4.10 美元
** CDXC 周四晚些时候公布的第三季度利润为每小时 2 美分，而分析师预计为盈亏平衡--LSEG 数据
** 由于对 NAD(烟酸腺嘌呤二核苷酸) 补充剂的需求强劲，该公司第三季度营收为 2558 万美元，高于分析师预计的 2364 万美元 。
** NAD 是一种重要的辅酶，是细胞新陈代谢的关键调节剂，存在于人体的每个细胞中。
** 截至上一交易日收盘，股价在年初翻了一番多
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.